Basic Information
Chimeron Bio was founded in 2015 and has developed a drug for personalized cancer gene therapy. The company focuses on the discovery and development of personalized immunotherapies, revolutionizing the way cancer is treated.
Chimeron Bio Corp
Philadelphia,Pennsylvania,United States of America
less than 15 people
January 01, 2015
contact@chimeron.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios